Dyskinesias D020820

Description

Abnormal involuntary movements which primarily affect the extremities, trunk, or jaw that occur as a manifestation of an underlying disease process. Conditions which feature recurrent or persistent episodes of dyskinesia as a primary manifestation of disease may be referred to as dyskinesia syndromes (see MOVEMENT DISORDERS). Dyskinesias are also a relatively common manifestation of BASAL GANGLIA DISEASES.   MeSH

Subtype Terms (13)

Ataxia
9 drugs (7 approved, 2 experimental)

Athetosis
1 approved drug

Catalepsy
 

Chorea
10 drugs (8 approved, 2 experimental)

Dyskinesia, Drug-Induced
12 drugs (7 approved, 5 experimental)

Dystonia
17 drugs (13 approved, 4 experimental)

Hyperkinesis
2 drugs (1 approved, 1 experimental)

Hypokinesia
3 drugs (1 approved, 2 experimental)

Myoclonus
13 drugs (11 approved, 2 experimental)

Psychomotor Agitation
32 drugs (29 approved, 3 experimental)

Synkinesis
2 approved drugs

Tics
2 approved drugs

Tremor
12 drugs (10 approved, 2 experimental)


Approved Indicated Drugs (1)

Phase 1 Indicated Drugs (1)


Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.